Company news

Hercules Capital, Inc. (NYSE:HTGC) news

Hercules Capital, Inc. news releases on 6ix. Latest, Oct 5, 2026: Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes…

Hercules Capital, Inc. (NYSE:HTGC) news

Press releases & updates

Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029

Hercules Capital Announces the Appointment of Alfred B. Fichera to Its Board of Directors

Hercules Capital’s Investment Adviser Surpasses $2.3 Billion in Investable Capital

Hercules Capital Reports Second Quarter 2026 Financial Results

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2026

Hercules Capital Closes Institutional Notes Offering of $325.0 Million 6.300% Unsecured Notes due 2031

Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031

Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call

Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders

Hercules Capital Reports First Quarter 2026 Financial Results

Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026

Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call

Hercules Capital Sets New Record with All-Time High New Debt and Equity Commitments

enGene Reports First Quarter 2026 Financial Results and Provides Business Update

Hercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRS

Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor

Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results

Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029

Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2025

Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call

Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™

Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*

enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.

HawkEye 360 Closes Strategic Acquisition and Secures Series E Preferred and Debt

Hercules Capital Announces Upcoming Event for the Financial Community

Hercules Capital Reports Third Quarter 2025 Financial Results

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2025

Hercules Capital Celebrates $25.0 Billion Milestone in Total Cumulative Debt Commitments

Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million

Hercules Capital Announces Date for Release of Third Quarter 2025 Financial Results and Conference Call

Tipalti Secures $200 Million in Growth Financing to Drive Next Wave of AI Innovation in Finance

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

Hercules Capital Receives Investment Grade Rating Upgrade to Baa2 With Revised Outlook to Stable From Moody’s Investors Service

Strive Health Raises $550 Million in Series D Funding

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.

Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile

Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

Hercules Capital Reports Second Quarter 2025 Financial Results

Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2025

Hercules Capital’s Wholly-Owned Investment Adviser Launches Fourth Institutional Private Credit Fund

Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital

Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030

Hercules Capital Renews and Increases Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million